INOVIO to present new DNA medicine research at major gene therapy and oncology conferences in May 2026

Biotech company INOVIO announced its participation in two key scientific conferences in May 2026: the American Society of Gene and Cell Therapy Annual Meeting in Boston and the American Society of Clinical Oncology Annual Meeting in Chicago. INOVIO will present research on gene therapy for hemophilia A and DNA immunotherapy for recurrent respiratory papillomatosis. These presentations highlight INOVIO's ongoing development of DNA medicines targeting HPV-related diseases, cancer, and infectious diseases. Abstracts from the presentations will be available on INOVIO's website after the events.